Medicare Enrolled

Dr. Gary Starkman, M.D.

Neurology · New York, NY
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
1035 PARK AVE, New York, NY 10028
2129871000
In practice since 2006 (20 years)
NPI: 1487686119 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Starkman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Starkman? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Starkman

Dr. Gary Starkman is a neurology specialist in New York, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Starkman performed 115,122 Medicare services across 619 unique beneficiaries.

Between the years covered by Open Payments, Dr. Starkman received a total of $2,155 from 23 pharmaceutical and/or device companies across 115 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Starkman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 0% volume in NY $2,155 industry payments

Medicare Practice Summary

Medicare Utilization ↗
115,122
Medicare services
Top 0% in NY for neurology
619
Unique beneficiaries
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~5,756 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Botox injection, per unit
An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered.
113,865 $5 $7
Ultrasound guidance for needle placement
Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure.
258 $49 $69
Chemical nerve block for neck muscles
Injection of a chemical agent to paralyze specific muscles on the side of the neck, excluding the voice box.
229 $201 $270
Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle 219 $65 $117
Methylprednisolone acetate injection, 80 mg
An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication.
141 $8 $11
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
83 $72 $113
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
82 $96 $164
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
58 $47 $75
Hyaluronan gel injection for joint
An injection of hyaluronan gel into a joint to supplement joint fluid. This procedure is administered as a single dose.
44 $402 $1,036
Destruction of peripheral nerve or branch 41 $227 $305
Ultrasound-guided large joint aspiration or injection
This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint.
33 $121 $188
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
32 $52 $135
Ultrasound of head and neck blood flow, bilateral
An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck.
13 $147 $246
Sacral spine nerve root injection with imaging guidance
An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement.
12 $322 $496
Additional sacral spine nerve root injection with imaging
An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging.
12 $156 $304
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,155
Total received (2018-2024)
Avg $308/year across 7 years
Top 44% in NY for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
23
Companies
115
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,155 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$152
2023
$184
2022
$311
2021
$154
2020
$186
2019
$388
2018
$780

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$79
Amgen Inc.
$74
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Bioventus LLC
$297
Supernus Pharmaceuticals, Inc.
$251
ABBVIE INC.
$226
AbbVie Inc.
$209
Allergan Inc.
$189
Novartis Pharmaceuticals Corporation
$180
Amneal Pharmaceuticals LLC
$154
Amgen Inc.
$119
Allergan, Inc.
$86
DePuy Synthes Sales Inc.
$78
Impax Laboratories, Inc.
$58
Bausch Health US, LLC
$46
Teva Pharmaceuticals USA, Inc.
$44
Biogen, Inc.
$42
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$32
Vertical Pharmaceuticals, LLC
$32
UCB, Inc.
$21
Celgene Corporation
$17
Grifols USA, LLC
$17
Almatica Pharma LLC
$17
Horizon Therapeutics plc
$15
Purdue Pharma L.P.
$13
Boston Scientific Corporation
$11
Top 3 companies account for 35.9% of all-time payments
Associated products mentioned in payments ›
AIMOVIG · AJOVY · Aimovig · BOTOX · BOTOX THERAPEUTIC · DIVIGEL · DUOPA · Durolane · GENERAL DBS · Gamunex-C · LUCEMYRA · METHYLPHENIDATE 72 · NAPRELAN · ORTHOVISC · OXTELLAR XR · QULIPTA · RYTARY · SYMPROIC · Supartz · TROKENDI XR · UBRELVY · UPLIZNA · Vimpat · WELLBUTRIN · ZEPOSIA · ZOMIG
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a neurology specialist in New York?
Compare neurologists in the New York area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
1,273
Per 100K population
78.2
County median income
$104,553
Nearest hospital
LENOX HILL HOSPITAL
0.3 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Starkman is a mixed practice specialist, with above-average Medicare volume (top 0% in NY), with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Starkman experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Starkman performed 113,865 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Starkman receive payments from pharmaceutical companies?
Yes. Dr. Starkman received a total of $2,155 from 23 companies across 115 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Starkman's costs compare to other neurologists in New York?
Dr. Starkman's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Starkman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →